ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $46.6B | +8.1% | 5.1% | 8.1% |
| Revenue (TTM) | $46.6B |
|---|---|
| YoY | +8.1% |
| 5-year CAGR | 5.1% |
| 10-year CAGR | 8.1% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $44.3B | +5.7% |
| 2024 | $42.0B | +4.6% |
| 2023 | $40.1B | −8.1% |
| 2022 | $43.7B | +1.3% |
| 2021 | $43.1B | +24.5% |
| 2020 | $34.6B | +8.5% |
| 2019 | $31.9B | +4.3% |
| 2018 | $30.6B | +11.6% |
| 2017 | $27.4B | +31.3% |
| 2016 | $20.9B | +2.2% |
| 2015 | $20.4B | +0.8% |
| 2014 | $20.2B | +3.0% |
| 2013 | $19.7B | +3.2% |
| 2012 | $19.1B | −11.0% |
| 2011 | $21.4B | −39.1% |
| 2010 | $35.2B | +14.3% |
| 2009 | $30.8B | +4.2% |
| 2008 | $29.5B | +13.9% |
| 2007 | $25.9B | — |